Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Cadrenal Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22
   10-Q10-Q10-Q
Revenues  0.05.20.0
Cost of goods sold  0.00.00.0
Gross profit  0.05.20.0
            Gross margin   100.0% 
Selling, general and administrative   [+]0.81.00.3
Research and development  0.23.20.2
Other operating expenses   5.2 
EBITDA   [+]-1.0-4.2 
            EBITDA margin   -81.2% 
Depreciation and amortization  0.00.0 
EBIT   [+]-1.0-4.2-0.5
            EBIT margin   -81.2% 
Interest income, net   [+]0.00.00.0
Other income (expense), net   [+]1.04.20.5
Pre-tax income  0.00.00.0
Income taxes  0.00.00.0
Net income  0.00.00.0
            Net margin   0.0% 
   
Basic EPS  $0.00$0.00$0.00
Diluted EPS  $0.00$0.00$0.00
   
Shares outstanding (basic)   [+]11.710.87.7
Shares outstanding (diluted)   [+]11.710.87.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy